Yocca Frank

CIK 00017332721 companyNEW HAVEN, CT

SEC Profile

Transactions

Companies

Filings

CIK

0001733272

Recent Transactions

50 trades

Award
BioXcel Therapeutics, Inc.$BTAI
Restricted Stock Units
2026-01-01+70,000→ 70,282 total
Exercise/Conversion
BioXcel Therapeutics, Inc.$BTAI
Restricted Stock Units
2025-09-15−35→ 317 total
Exercise/Conversion
BioXcel Therapeutics, Inc.$BTAI
Common Stock
2025-09-15+35→ 6,384 total
Exercise/Conversion
BioXcel Therapeutics, Inc.$BTAI
Common Stock
2025-09-14+33→ 6,349 total
Exercise/Conversion
BioXcel Therapeutics, Inc.$BTAI
Restricted Stock Units
2025-09-14−33→ 163 total
Award
BioXcel Therapeutics, Inc.$BTAI
Restricted Stock Units
2025-08-01+9,000→ 9,000 total
Award
BioXcel Therapeutics, Inc.$BTAI
Common Stock
2025-07-22+4,375→ 6,316 total
Exercise/Conversion
BioXcel Therapeutics, Inc.$BTAI
Common Stock
2025-06-15+35→ 1,941 total
Exercise/Conversion
BioXcel Therapeutics, Inc.$BTAI
Restricted Stock Units
2025-06-15−35→ 352 total
Exercise/Conversion
BioXcel Therapeutics, Inc.$BTAI
Common Stock
2025-06-14+33→ 1,906 total
Exercise/Conversion
BioXcel Therapeutics, Inc.$BTAI
Restricted Stock Units
2025-06-14−33→ 196 total
Exercise/Conversion
BioXcel Therapeutics, Inc.$BTAI
Common Stock
2025-03-15+34→ 1,873 total
Exercise/Conversion
BioXcel Therapeutics, Inc.$BTAI
Restricted Stock Units
2025-03-15−34→ 387 total
Exercise/Conversion
BioXcel Therapeutics, Inc.$BTAI
Common Stock
2025-03-14+31→ 1,839 total
Exercise/Conversion
BioXcel Therapeutics, Inc.$BTAI
Restricted Stock Units
2025-03-14−31→ 229 total
Award
BioXcel Therapeutics, Inc.$BTAI
Stock Option (right to buy)
2025-01-07+270,000→ 270,000 total
Sale
BioXcel Therapeutics, Inc.$BTAI
Common Stock
2024-12-16$0.35/sh−225→ 28,931 total
Sale
BioXcel Therapeutics, Inc.$BTAI
Common Stock
2024-12-16$0.36/sh−205→ 29,156 total
Exercise/Conversion
BioXcel Therapeutics, Inc.$BTAI
Restricted Stock Units
2024-12-15−562→ 5,064 total
Exercise/Conversion
BioXcel Therapeutics, Inc.$BTAI
Common Stock
2024-12-15+562→ 29,361 total
Exercise/Conversion
BioXcel Therapeutics, Inc.$BTAI
Common Stock
2024-12-14+521→ 28,799 total
Exercise/Conversion
BioXcel Therapeutics, Inc.$BTAI
Restricted Stock Units
2024-12-14−521→ 2,606 total
Sale
BioXcel Therapeutics, Inc.$BTAI
Common Stock
2024-10-03$0.55/sh−7,175→ 28,278 total
Award
BioXcel Therapeutics, Inc.$BTAI
Common Stock
2024-09-17+21,250→ 35,453 total
Sale
BioXcel Therapeutics, Inc.$BTAI
Common Stock
2024-09-16$0.69/sh−355→ 14,203 total
Exercise/Conversion
BioXcel Therapeutics, Inc.$BTAI
Restricted Stock Units
2024-09-15−563→ 5,625 total
Exercise/Conversion
BioXcel Therapeutics, Inc.$BTAI
Common Stock
2024-09-15+563→ 14,558 total
Exercise/Conversion
BioXcel Therapeutics, Inc.$BTAI
Common Stock
2024-09-14+521→ 13,995 total
Exercise/Conversion
BioXcel Therapeutics, Inc.$BTAI
Restricted Stock Units
2024-09-14−521→ 3,127 total
Award
BioXcel Therapeutics, Inc.$BTAI
Stock Option (right to buy)
2024-07-22+1,875→ 1,875 total
Sale
BioXcel Therapeutics, Inc.$BTAI
Common Stock
2024-06-17$1.28/sh−372→ 13,474 total
Exercise/Conversion
BioXcel Therapeutics, Inc.$BTAI
Restricted Stock Units
2024-06-15−562→ 6,188 total
Exercise/Conversion
BioXcel Therapeutics, Inc.$BTAI
Common Stock
2024-06-15+562→ 13,846 total
Exercise/Conversion
BioXcel Therapeutics, Inc.$BTAI
Common Stock
2024-06-14+521→ 13,284 total
Exercise/Conversion
BioXcel Therapeutics, Inc.$BTAI
Restricted Stock Units
2024-06-14−521→ 3,648 total
Sale
BioXcel Therapeutics, Inc.$BTAI
Common Stock
2024-04-04$2.63/sh−1,067→ 12,763 total
Exercise/Conversion
BioXcel Therapeutics, Inc.$BTAI
Common Stock
2024-03-15+2,250→ 13,830 total
Exercise/Conversion
BioXcel Therapeutics, Inc.$BTAI
Restricted Stock Units
2024-03-15−2,250→ 6,750 total
Exercise/Conversion
BioXcel Therapeutics, Inc.$BTAI
Common Stock
2024-03-14+521→ 11,580 total
Exercise/Conversion
BioXcel Therapeutics, Inc.$BTAI
Restricted Stock Units
2024-03-14−521→ 4,169 total
Exercise/Conversion
BioXcel Therapeutics, Inc.$BTAI
Common Stock
2023-12-14+521→ 11,059 total
Exercise/Conversion
BioXcel Therapeutics, Inc.$BTAI
Restricted Stock Units
2023-12-14−521→ 4,690 total
Exercise/Conversion
BioXcel Therapeutics, Inc.$BTAI
Restricted Stock Units
2023-09-14−521→ 5,211 total
Exercise/Conversion
BioXcel Therapeutics, Inc.$BTAI
Common Stock
2023-09-14+521→ 10,538 total
Exercise/Conversion
BioXcel Therapeutics, Inc.$BTAI
Restricted Stock Units
2023-06-14−521→ 5,732 total
Exercise/Conversion
BioXcel Therapeutics, Inc.$BTAI
Common Stock
2023-06-14+521→ 10,017 total
Sale
BioXcel Therapeutics, Inc.$BTAI
Common Stock
2023-03-15$19.69/sh−985→ 9,496 total
Award
BioXcel Therapeutics, Inc.$BTAI
Stock Option (Right to Buy)
2023-03-15+32,000→ 32,000 total
Award
BioXcel Therapeutics, Inc.$BTAI
Restricted Stock Units
2023-03-15+9,000→ 9,000 total
Exercise/Conversion
BioXcel Therapeutics, Inc.$BTAI
Common Stock
2023-03-14+2,084→ 10,481 total

Companies

BioXcel Therapeutics, Inc.
Chief Scientific Officer
$BTAI

Recent Filings

Address

C/O BIOXCEL THERAPEUTICS, INC. 555 LONG WHARF DRIVE, 12TH FLOOR

NEW HAVEN, CT, 06511

View on SEC.gov